Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens.
Larghero
J
J
Zassadowski
F
F
Rousselot
P
P
Padua
R A
RA
Degos
L
L
Chomienne
C
C
D015972:Gene Expression Regulation, Neoplastic; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000235:genetics* / Q000276:immunology*; D009363:Neoplasm Proteins / Q000235:genetics*; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D000090063:Proto-Oncogene Mas; D014157:Transcription Factors / Q000235:genetics*; D025521:Tumor Suppressor Proteins
D015395:Histocompatibility Antigens Class I; C000715470:MAS1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D000090063:Proto-Oncogene Mas; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C070576:PML protein, human